| Protocol ID |
|
Title |
|
| GOG 273 |
|
Chemotherapy Toxicity in Elderly Women with Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Keywords: Ovarian, Primary Peritoneal, or Fallopian Tube Cancer |
|
| GOG 267 |
|
Quality of Life and Care Needs in Patients with Persistent or Recurrent Platinum-Resistant Ovarian, Fallopian Tube, and Peritoneal Cancer
Keywords: Persistant or recurrent Ovarian, Fallopian Tube, and Peritoneal Cancer |
|
GOG 0263
|
|
Phase III RT vs RT with Chemo in Stage I/IIA Cervical Cancer
Keywords: Stage I/IIA Cervical Cancer |
|
GOG 0272
|
|
Pilot Study of Standard Therapy for Prevention of Nausea Associated with First Line Post-Operative Intraperitoneal Chemotherapy
Keywords: Intraperitoneal Chemotherapy |
|
GOG 0213
|
|
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel Alone in Combination with Bevacizumab (NSC #704965, IND #7921) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum- Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer
Keywords: Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer |
|
RTOG 0724
|
|
Phase III Randomized Study of Concurrent Chemotherapy and Pelvic Radiation Therapy with or without Adjuvant Chemotherapy in High Risk Patients with Early-Stage Cervical Carcinoma following Radical Hysterectomy
Keywords: High Risk Patients with Early-Stage Cervical Carcinoma following Radical Hysterectomy |
|
EMBRACE
|
|
A European study on MRI-guided Brachytherapy in Locally Advanced Cervical Cancer
Keywords: Locally Advanced Cervical Cancer |
|
GOG0258
|
|
A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma
Keywords: Advanced Endometrial Carcinoma |
|
GOG0235
|
|
A Prospective, Longituidinal Study of YKL-40 in Patients with FIGO Stage III or IV Invasive Epithelal Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Undergoing Primary Chemotherapy
Keywords: Patients with FIGO Stage III or IV Invasive Epithelal Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Undergoing Primary Chemotherapy |
|
GOG 261
|
|
A Randomized Phase III Trial of Paclitaxel Plus Carboplatin v. Ifosfamide plus Paclitaxel in Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus or Ovary
Keywords: Stage I-IV, Persistent or Recurrent Carcinosarcoma |
|
GOG 0212
|
|
A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paxlitaxel or CT-2103 (IND #70177) versus No Treatment until Documented relapse in Women with Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Response to Primary Platinum/ Taxane Chemotherapy
Keywords: relapse in Women with Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer |
|
In-house — MRI
|
|
Investigation of the Utility of Advanced MRI Imagine Methods for Radiation Therapy Treatment Planning
Keywords: Advanced MRI Imagine Methods for Radiation Therapy Treatment Planning (Brain, Breast, Head & Neck, Lung, Cervix, Sarcoma, Prostate, or Liver and Liver Mets) |
|
GOG 0268
|
|
A Phase II Evaluation of Temsirolimus (CCI-779) (NCI Supplied Agent: NSC #683864, IND #61010) in Combination with Carboplatin and Paclitaxel Followed by Temsirolimus (CCI-779) Consolidation as First Line Therapy in the Treatment of Stage III-IV Clear Cell Carcinoma of the Ovary
Keywords: Clear Cell Carcinoma of the Ovary |
|
GOG 274
|
|
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: the OUTBACK TRIAL
Keywords: Locally Advanced Cervical Cancer |
|
In-house psychosocial
|
|
Study Analyzing the Use of the Dialectical Behavior Therapy (DBT) Skills Set and Psychosocial Stress with Cancer Patients
Keywords: Breast, Gyn, GI, GU Dialectical Behavior Therapy (DBT) |
|
GOG 241
|
|
A GCIG Intergroup Multicenter Phase III Trial of Open Label Carboplatin and Paclitaxel +/- NCI-Supplied Agent: Bevacizumab Compared with Oxaliplatin and Capecitabine +/- Bevacizumab as First Line Chemotherapy in Patients with Mucinous Epithelial Ovarian or Fallopian Tube Cancer (MEOC)
Keywords: Mucinous Epithelial Ovarian or Fallopian Tube Cancer (MEOC) |
|
GOG 244
|
|
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and Impact in Newly Diagnosed Patients
Keywords: Lymphedema and Gynecologic Cancer |
|
GOG 0225
|
|
Can Diet and Exercise Modulate Ovarian, Fallopian Tube or Peritoneal Cancer Progression-Free Survival
Keywords: Ovarian, Fallopian Tube or Peritoneal Cancer |
|
GOG 9928
|
|
A Phase I Study of Intraperitoneal Egen-001 Administered in Combination with Pegylated Liposomal-Doxorubicin in Patients with Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Keywords: Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
|
GOG 3001
|
|
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of AMG 386 With Paclitaxel and Carboplatin as First-line Treatment of Subjects With FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers (Amgen Protocol #20101129)
Keywords: FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers |
|
Industry — Ovarian Cancer
|
|
A Study of MK-1775 in Combination with Paclitaxel and Carboplatin versus Paclitaxel and Carboplatin Alone in Adult Patients with Platinum Sensitive p53 Mutant Ovarian Cancer
Keywords: Platinum Sensitive p53 Mutant Ovarian Cancer |